17 HANOVER SQUARE, LONDON, X0
CEO and COO Appointments - Ian Huen and Alidad Mireskandari Named
Operating and Financial Review and Prospects
Amended material disclosure
Other Events
Provides Update on DiamiR Biosciences Merger
Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences
Files Pre-Effective Amendment No. 4 to Form S-4 Registration Statement
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
RW
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-4/A
No filings found
Initial Statement of Beneficial Ownership
Schedule 13D - Ownership Report
Amended Schedule 13D - Ownership Report
Amended Schedule 13G - Ownership Report
Post-Effective Amendment to Registration Statement
Delisting Amendment
Submission Upload
Correspondence